Table 4. Adverse events.

Outcome	Overall (n = 87)	Poractant alfa (n = 42)	Bovine lipid extract surfactant (n = 45)	Odds Ratio (95% CI)	Odds Ratio Adjusted for Strata (95% CI)	P Value
Adverse events during or after surfactant administration
Severe airway obstruction; n	5	0	5	0.09 (< 0.01, 1.67)	0.09 (< 0.01, 1.28)	0.07
Need for cardiopulmonary resuscitation; n	2	0	2	0.21 (< 0.01, 4.55)	0.33 (0.03–3.57)	0.36
Pulmonary hemorrhage; n	5	2	3	0.75 (0.14–4.10)	0.87 (0.18–4.31)	0.87
Pneumothorax; n	8	3	5	0.65 (0.16–0.56)	0.59 (0.14–2.51)	0.47
Pulmonary interstitial emphysema; n	2	1	1	1.07 (0.10–11.01)	2.74 (0.28–26.74)	0.39